Hassan Zeb, MD
Pulmonary Disease · North Little Rock, ARNPI 1114302650
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,387 of the $13,257 with a category attached, or 85.9%. It is spread thinly across 38 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $4,469, more than ten times the $446 reported in 2019.
Across 523 payments — averaging $25.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$2K
- Intuitive Surgical$2K
- AstraZeneca$2K
- Boehringer Ingelheim$1K
- Regeneron Healthcare Solutions, Inc.$811
- Actelion Pharmaceuticals US, Inc.$741
- plus $5K from 32 others
What the payments were for
- Travel & lodging$1,41711%
- Food & beverage$11,38786%
- Education$4523%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 103 | $1,774 |
| Intuitive Surgical | 10 | $1,763 |
| AstraZeneca | 93 | $1,754 |
| Boehringer Ingelheim | 61 | $1,462 |
| Regeneron Healthcare Solutions, Inc. | 30 | $811 |
| Actelion Pharmaceuticals US, Inc. | 19 | $741 |
| United Therapeutics Corporation | 27 | $666 |
| Sanofi | 28 | $605 |
| Grifols USA, LLC | 18 | $402 |
| Baxter Healthcare | 16 | $382 |
| Mallinckrodt Hospital Products Inc. | 10 | $343 |
| Electromed, Inc. | 15 | $309 |
| Mylan Specialty L.p. | 14 | $273 |
| Sanofi-aventis U.S. LLC | 3 | $239 |
| Genentech USA, Inc. | 12 | $201 |
| Stryker | 1 | $184 |
| Insmed, Inc. | 8 | $153 |
| AbbVie | 8 | $139 |
| Amgen | 7 | $124 |
| Steris Corporation | 1 | $123 |
| Viatris Specialty LLC | 5 | $115 |
| Philips North America LLC | 5 | $96 |
| Pfizer | 4 | $81 |
| Verona Pharma, Inc. | 4 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70 |
| Merck | 3 | $65 |
| Melinta Therapeutics, LLC | 2 | $52 |
| Johnson & Johnson | 3 | $47 |
| Pulmonx Corporation | 1 | $29 |
| ZOLL Circulation Inc | 1 | $27 |
| Bayer | 1 | $25 |
| Theratechnologies Inc. | 1 | $25 |
| ANI Pharmaceuticals, Inc. | 1 | $24 |
| Kedrion Biopharma, Inc. | 1 | $18 |
| Vifor Pharma, Inc. | 1 | $16 |
| Advanced Respiratory, Inc | 1 | $15 |
| Nevro Corp. | 1 | $13 |
| Sandoz | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$1,522
- UPTRAVI$362
- OPSUMIT$362
- FLOWTRIEVER CATHETER, S$184
- CT THROMBECTOMY SYSTEM KIT$184
- SMARTVEST$134
- TRUFREEZE$123
- NUCALA$122
How this compares
$13,257 in reported general payments places this provider in the 85th percentile of 102 pulmonary disease providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 24 | $314,779 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 203 | $146,427 |
| Prolastin CAlpha-1-Proteinase Inhibitor | 11 | $118,424 |
| Spiriva RespimatTiotropium Bromide | 95 | $60,028 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 102 | $45,243 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 41 | $25,255 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 43 | $17,271 |
| Incruse ElliptaUmeclidinium Bromide | 45 | $15,482 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 17 | $12,220 |
| SymbicortBudesonide/Formoterol Fumarate | 35 | $9,971 |
| Advair HfaFluticasone Propion/Salmeterol | 11 | $4,420 |
| Arnuity ElliptaFluticasone Furoate | 19 | $3,837 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 113 | $3,132 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 21 | $2,207 |
| Ventolin HfaAlbuterol Sulfate | 23 | $1,293 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev, Spiriva Respimat, Stiolto Respimat | $1,462 | $420,050221 claims |
| GSKTrelegy Ellipta, Incruse Ellipta, Anoro Ellipta, Arnuity Ellipta | $1,774 | $177,966284 claims |
| Grifols USA, LLCProlastin C | $402 | $118,42411 claims |
| AstraZenecaBreztri Aerosphere, Bevespi Aerosphere, Symbicort | $1,754 | $52,497119 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 102 pulmonary disease providers in Arkansas.
Other pulmonary disease in North Little Rock
- Zafirah SalmanNorth Little Rock$18K
- Dominika SzwedoNorth Little Rock$17K
- Muhammad AliNorth Little Rock$11K
- Ladly AbrahamConway$371K
- Daniel PaulRogers$244K
- Jason McKinneyRogers$86K
- Arturo MeadeFort Smith$67K
- Nikhil MeenaLittle Rock$63K
- Penchala MittadodlaRogers$21K
- Mark SiffordJonesboro$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.